MedicaidPrior AuthMedium impact
25-1084 New Policy Expands Access to Hepatitis C Treatment
Health Net·CA · Gastroenterology, Infectious Disease, Internal Medicine +1 more·Prior Authorization
Effective date
Oct 1, 2025
We identified it
Jun 20, 2026
Summary
Effective October 1, 2025, Medi-Cal RX has eliminated the 28-day supply limitation for Hepatitis C treatments, now allowing physicians to dispense up to a 12-week supply per fill. This removes prior authorization barriers and enables full-course dispensing for eligible Hepatitis C treatments under Medi-Cal.
Action Required
By October 1, 2025: Billing team must update Medi-Cal RX dispensing protocols to allow up to 12-week supplies for Hepatitis C treatments including Glecaprevir/Pibrentasvir and Sofosbuvir/Velpatasvir. Remove 28-day supply limitations from billing system rules. Notify providers they can now prescribe full-course dispensing without prior authorization restrictions for eligible patients in affected California counties.